Genmab reported DKK2.12B in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Amarin AMRN:US $ 94.44M 0.19M
Amgen AMGN:US $ 6594M 356M
Artemis Alpha ATS:LN -9335000 58.77M
AstraZeneca AZN:LN 10771M 619M
Bayer BAYN:GR € 12819M 1820M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Exelixis EXEL:US $ 419.43M 63.45M
Fresenius Medical Care FME:GR € 4757M 208.63M
Galapagos GLPG:NA € 147.57M 3.54M
Genmab GEN:DC DK 2119M 500M
GlaxoSmithKline GSK:LN 6929M 2851M
GN Store Nord GN:DC DK 3859M 241M
Hikma Pharmaceutical HIK:LN 1.21B 124M
Immunogen IMGN:US $ 14.16M 23.92M
Insmed INSM:US $ 65.22M 12.11M
Lonza Group LONN:SW 2.98B 115M
Merck MRK:GR € 5568M 370M
Novartis NOVN:VX SF 13085M 271M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Seattle Genetics SGEN:US $ 497.5M 71.04M
William Demant Holding WDH:DC 9.38B 364M